Skip to content

Clinical trials

Osteoporosis, Postmenopausal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis, Postmenopausal Clear all

330 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
200211
200314
200420
20056
200621
200712
20088
200916
20109
201112
201216
20135
20146
20157
20166
201714
201817
201925
202010
202122
202218
202313
20245
202513
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed245
Unknown status36
Recruiting17
Active, not recruiting9
Withdrawn7
Not yet recruiting7
Terminated7
No longer available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company25
Amgen24
Hoffmann-La Roche21
Massachusetts General Hospital10
Sanofi10
Organon and Co9
GlaxoSmithKline7
Radius Health, Inc.7
Merck Sharp & Dohme LLC5
Warner Chilcott5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis, Postmenopausal330
Osteoporosis125
Bone Diseases, Metabolic45
Osteoporotic Fractures10
Bone Diseases8
Fractures, Bone7
Musculoskeletal Diseases6
Diabetes Mellitus, Type 25
Sarcopenia5
Spinal Fractures5

Trials

Showing 26 to 50 of 330. Each trial links to its page on Pharma Observatory.

230 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.